These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
534 related articles for article (PubMed ID: 27519616)
1. Male sexual dysfunction after rectal cancer surgery: Results of a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for patients with lower rectal cancer: Japan Clinical Oncology Group Study JCOG0212. Saito S; Fujita S; Mizusawa J; Kanemitsu Y; Saito N; Kinugasa Y; Akazai Y; Ota M; Ohue M; Komori K; Shiozawa M; Yamaguchi T; Akasu T; Moriya Y; Eur J Surg Oncol; 2016 Dec; 42(12):1851-1858. PubMed ID: 27519616 [TBL] [Abstract][Full Text] [Related]
2. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial. Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y; Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948 [TBL] [Abstract][Full Text] [Related]
3. Urinary dysfunction after rectal cancer surgery: Results from a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for clinical stage II or III lower rectal cancer (Japan Clinical Oncology Group Study, JCOG0212). Ito M; Kobayashi A; Fujita S; Mizusawa J; Kanemitsu Y; Kinugasa Y; Komori K; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Akasu T; Moriya Y; Eur J Surg Oncol; 2018 Apr; 44(4):463-468. PubMed ID: 29428473 [TBL] [Abstract][Full Text] [Related]
4. Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial. Fujita S; Mizusawa J; Kanemitsu Y; Ito M; Kinugasa Y; Komori K; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Bandou H; Katsumata K; Murata K; Akagi Y; Takiguchi N; Saida Y; Nakamura K; Fukuda H; Akasu T; Moriya Y; Ann Surg; 2017 Aug; 266(2):201-207. PubMed ID: 28288057 [TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of the randomized trial of mesorectal excision with or without lateral lymph node dissection in rectal cancer (JCOG0212). Tsukamoto S; Fujita S; Ota M; Mizusawa J; Shida D; Kanemitsu Y; Ito M; Shiomi A; Komori K; Ohue M; Akazai Y; Shiozawa M; Yamaguchi T; Bando H; Tsuchida A; Okamura S; Akagi Y; Takiguchi N; Saida Y; Akasu T; Moriya Y; Br J Surg; 2020 Apr; 107(5):586-594. PubMed ID: 32162301 [TBL] [Abstract][Full Text] [Related]
6. Potential sexual function improvement by using transanal mesorectal approach for laparoscopic low rectal cancer excision. Pontallier A; Denost Q; Van Geluwe B; Adam JP; Celerier B; Rullier E Surg Endosc; 2016 Nov; 30(11):4924-4933. PubMed ID: 26944728 [TBL] [Abstract][Full Text] [Related]
7. Postoperative morbidity and mortality after mesorectal excision with laparoscopic versus conventional open lateral lymph node dissection for advanced rectal cancer: A meta-analysis. Du R; Zhou J; Li D; Zhang Q; Liu J; Ma C; Wang L; Wang D Asian J Surg; 2021 Jan; 44(1):26-35. PubMed ID: 32798083 [TBL] [Abstract][Full Text] [Related]
8. Predictive factors of pathological lateral pelvic lymph node metastasis in patients without clinical lateral pelvic lymph node metastasis (clinical stage II/III): The analysis of data from the clinical trial (JCOG0212). Komori K; Fujita S; Mizusawa J; Kanemitsu Y; Ito M; Shiomi A; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Bandou H; Katsumata K; Kinugasa Y; Takii Y; Akasu T; Moriya Y; Eur J Surg Oncol; 2019 Mar; 45(3):336-340. PubMed ID: 30477950 [TBL] [Abstract][Full Text] [Related]
9. [Transanal lateral lymph node dissection surgery for 5 cases of mid-low rectal cancer]. Zeng ZW; Zhang XW; Chen JJ; Huang L; Luo SL; Kang L Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):781-785. PubMed ID: 31422618 [No Abstract] [Full Text] [Related]
10. [Short-term efficacy of robotic-assisted total mesorectal excision with and without lateral lymph node dissection for mid-low advanced rectal cancer: a propensity score matching analysis]. Shi FY; Zhang L; Qin Q; Jin X; Hu CH; Yu TY; Ma L; Wang GH; Wu H; Xia P; Sun XJ; She JJ Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Apr; 23(4):370-376. PubMed ID: 32306605 [No Abstract] [Full Text] [Related]
11. [Comparison on efficacy between fascia-oriented versus vascular-oriented lateral lymph node dissection in patients with rectal cancer]. Wang ZJ; Liu Z; Liang JW; Zhang MG; Mei SW; Shen HY; Chen JN; Li J; Zhao FQ; Wei FZ; Xiao TX; Liu Q Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Jul; 24(7):611-618. PubMed ID: 34289546 [No Abstract] [Full Text] [Related]
12. Is it time to rethink the rule of total mesorectal excision? A prospective radiological and pathological study in 49 consecutive patients with mid-rectal cancer. Guedj N; Zappa M; Maggiori L; Bertin C; Hennequin C; Panis Y Colorectal Dis; 2016 Sep; 18(9):O314-21. PubMed ID: 27381492 [TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of lateral lymph node dissection for patients with rectal cancer: A systematic review and meta-analysis. Ma P; Yuan Y; Yan P; Chen G; Ma S; Niu X; Xu M; Yang K; Cai H Asian J Surg; 2020 Sep; 43(9):891-901. PubMed ID: 31926817 [TBL] [Abstract][Full Text] [Related]
14. Lateral pelvic lymph node dissection after neoadjuvant chemo-radiation for preoperative enlarged lateral nodes in advanced low rectal cancer: study protocol for a randomized controlled trial. Wei M; Wu Q; Fan C; Li Y; Chen X; Zhou Z; Han J; Wang Z Trials; 2016 Nov; 17(1):561. PubMed ID: 27884204 [TBL] [Abstract][Full Text] [Related]
15. Potential impact of lateral lymph node dissection (LLND) for low rectal cancer on prognoses and local control: A comparison of 2 high-volume centers in Japan that employ different policies concerning LLND. Kanemitsu Y; Komori K; Shida D; Ochiai H; Tsukamoto S; Kinoshita T; Moriya Y Surgery; 2017 Aug; 162(2):303-314. PubMed ID: 28366499 [TBL] [Abstract][Full Text] [Related]
16. Laparoscopic pelvic autonomic nerve-preserving surgery for patients with lower rectal cancer after chemoradiation therapy. Liang JT; Lai HS; Lee PH Ann Surg Oncol; 2007 Apr; 14(4):1285-7. PubMed ID: 17235719 [TBL] [Abstract][Full Text] [Related]
17. Exploratory analysis of lateral pelvic sentinel lymph node status for optimal management of laparoscopic lateral lymph node dissection in advanced lower rectal cancer without suspected lateral lymph node metastasis. Yasui M; Ohue M; Noura S; Miyoshi N; Takahashi Y; Matsuda C; Nishimura J; Haraguchi N; Ushigome H; Nakai N; Fujino S; Sugimura K; Wada H; Takahashi H; Omori T; Miyata H BMC Cancer; 2021 Aug; 21(1):911. PubMed ID: 34380428 [TBL] [Abstract][Full Text] [Related]
18. Impact of autonomic nerve preservation and lateral node dissection on male urogenital function after total mesorectal excision for lower rectal cancer. Kyo K; Sameshima S; Takahashi M; Furugori T; Sawada T World J Surg; 2006 Jun; 30(6):1014-9. PubMed ID: 16736330 [TBL] [Abstract][Full Text] [Related]
19. Transanal Total Mesorectal Excision vs Laparoscopic Total Mesorectal Excision in the Treatment of Low and Middle Rectal Cancer: A Propensity Score Matching Analysis. Persiani R; Biondi A; Pennestrì F; Fico V; De Simone V; Tirelli F; Santullo F; D'Ugo D Dis Colon Rectum; 2018 Jul; 61(7):809-816. PubMed ID: 29771810 [TBL] [Abstract][Full Text] [Related]